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Selective IgA deficiency (IgAD) is the most common primary antibody deficiency in the 
western world with affected individuals suffering from an increased burden of autoimmu-
nity, atopic diseases and infections. It has been shown that IgAD B cells can be induced 
with germinal center mimicking reactions to produce IgA. However, IgA is the most 
prevalent antibody in mucosal sites, where antigen-independent responses are import-
ant. Much interest has recently focused on the role of TLR9 in both naïve and mature 
B cell differentiation into IgA secreting plasma cells. Here, we analyze the phenotype 
and function of T and B cells in individuals with IgAD following IgA-inducing CpG-TLR9 
stimulations. The IgAD individuals had significantly lower numbers of transitional B cells 
(CD19+CD24hiCD38hi) and class-switched memory B cells (CD20+CD27+IgD−) ex vivo. 
However, proportions of T cell populations ex vivo as well as in vitro induced T effector 
cells and T regulatory cells were comparable to healthy controls. After CpG stimulation, 
the transitional B  cell defect was further enhanced, especially within its B regulatory 
subset expressing IL-10. Finally, CpG stimulation failed to induce IgA production in IgAD 
individuals. Collectively, our results demonstrate a defect of the TLR9 responses in IgAD 
that leads to B cell dysregulation and decreased IgA production.
Keywords: selective iga deficiency, B cells, T cells, iga, cpg, T cell-independent B cell responses, Transitional 
B cells, B regulatory cells
inTrODUcTiOn
Selective IgA deficiency (IgAD) is the most common primary immune deficiency (PID), affecting 
about 1/700 individuals (1). It is characterized by IgA below <0.07 mg/dL with normal levels of 
IgG and IgM (2). IgA-deficient individuals are often asymptomatic, but are at an increased risk of 
diseases related to immune deregulation, autoimmune, and atopic diseases (3). The mechanisms 
Abbreviations: AimV, Aim V serum-free medium; ASC, antibody secreting cells; ANA, antinuclear antibodies; BCL6, B-cell 
lymphoma 6 protein; CCP, cyclic citrulinated peptides; CD40L, CD40 ligand, CD154 is an alternative name; CFSE, fluorescent 
5,6-carboxyfluorescein succinimidyl ester; CpG, CpG Oligodeoxynucleotide, TLR9 agonist.; EBV-B, Epstein–Barr transformed 
B cells; ELISA, enzyme-linked immunosorbent assay; ENA, extractable nuclear antigens; FoxP3, forkhead box P3; GATA3, 
trans-acting T-cell-specific transcription factor GATA-3; ICOS, inducible T-cell costimulator; IgAD, selective IgA deficiency; 
IMDM, Iscove’s modified Dulbecco’s medium; IFNγ, interferon gamma; n/iTreg, natural/induced T regulatory cells; PB, periph-
eral blood; PBMC, peripheral blood mononuclear cells; PD1, programmed cell death protein 1; RF, Rheumatoid factor; RORγT, 
Retineic-acid-receptor-related orphan nuclear receptor gamma; SEA, SEB, SEE, Staphylococcal enterotoxins; SLE, systemic 
lupus erythematosus; Tbet, T-box transcription factor TBX21; TFH, T follicular helper cell; TGF-β1, transforming growth 
factor beta 1; TGF-β1, transforming growth factor beta 1; TH1/2/17/22, T helper cell 1/2/17/22, TLR9, toll-like receptor 9.
TaBle 1 | Demographics of healthy controls (HC) and IgAD patients (IgAD).
hc igaD p Value
Age (mean ± SD years) 51(±12.5) 57(±11)
M/F ratio 1 0.6
IgM 1.0 ± 0.4 1.1 ± 0.4
IgG 10.6 ± 3.1 14.8 ± 3.2 g/l <0.0001
IgG1 7.1 ± 2.5 11.3 ± 3.5 g/l <0.0001
IgG 2 3.4 ± 1.8 2.9 ± 1.2 g/l
IgG3 0.4 ± 0.22 0.4 ± 0.3 g/l
IgG4 0.4 ± 0.3 0.2 ± 0.2 g/l
Autoantibody+ 20% 53%
Antinuclear antibodies (ANA+) 0% 40%
Extractable nuclear antigens (ENA+) 0% 26%
Rheumatoid factor (RF+) 13% 20%
RF IgM+ 0% 0%
RF IgG+ 0% 0%
Cyclic citrulinated peptides (CCP+) 20% 33%
Table depicts age, male to female ratio (M/F ratio), prevalence of autoimmunity, 
IgM, IgG, and IgG subgroups, and the prevalence of autoantibodies (ANA, ENA, RF, 
and CCP) in the IgAD group examined. Statistical comparison of IgAD and HC was 
calculated using one-way ANOVA for IgM, IgG, IgG1, IgG2, IgG3, and IgG4.
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leading to IgAD are most likely multifactorial involving several 
potential immunological pathways that are also common to the 
immunopathogenesis of autoimmunity, atopy, and infectious dis-
eases (4). As has been the case with the elucidation of other PIDs, 
understanding the mechanisms leading to IgAD may deepen 
our understanding of the immune system, and could pave the 
way for a personalized approach to the diseases affecting these 
individuals (5). In addition, it is also well known that IgAD can 
develop into a more severe antibody deficiency phenotype such 
as common variable immunodeficiency or IgG deficiency, this is 
especially true for cases, where a TNFRSF13B coding variant is 
associated with the defect (6).
IgA is the most abundant antibody isotype produced in the 
body, and is secreted by terminally differentiated antibody secret-
ing cells (ASC) (7). Although detected at a high concentration 
in blood, the most vital role of IgA is predominantly to interact 
locally with pathogens and antigens at mucosal surfaces (8). The 
mechanisms leading to the differentiation and survival of B cells 
to become ASCs are dictated by a variety of control mechanisms, 
including class switching, homing, co-stimulation, and finally 
commitment to a plasma cell lineage (7). Since the defect in IgA 
production in IgAD individuals could be due to a defect in any 
of these mechanisms it is important to delineate which pathways 
are defective as well as those functioning correctly in IgAD 
individuals.
Bone marrow transplantation in individuals with IgAD 
can cure the deficiency suggesting that the defect is of hemat-
opoietic origin (9). A phenotypic analysis of peripheral blood 
(PB) lymphocytes in individuals suffering from IgAD has led 
to the prevailing view that defects in numbers and function of 
certain lymphocyte populations might be the main cause of IgA 
deficiency (10–12). Advances in multicolor flow cytometry and 
better biological understanding of B cell maturation have led to 
renewed interest in detailed phenotypic analysis of B cells and 
T cells in immune-mediated diseases. Some of the older studies 
about IgAD have shown lower numbers of switched memory 
B cells, classified as IgD-CD27+, and transitional B cells, classified 
as CD38hiIgM+ (12, 13) in adult donors. A more appropriate phe-
notypic definition of transitional B cells would be CD24hiCD38hi. 
A recent study found that this population to be within the nor-
mal range in pediatric IgAD individuals (14). It is of note that 
transitional B cells represent the majority of B cells in children 
and may, therefore, have a different function than in adults (14). 
Transitional B cells have not been studied so far in adult IgAD 
donors, and current knowledge on lymphocyte subpopulations 
could be greatly enhanced by recent advances in multicolor 
flow cytometry and better understanding of the biology of B cell 
maturation and differentiation. Transitional B  cells have been 
shown to be important regulators of the immune system, in 
part through their IL-10 secretion and their B regulatory (Breg) 
phenotype assessed by IL-10 expression (15). They have been 
suggested to have a role in the pathogenesis of IgA-mediated 
diseases, such as IgA nephropathy (16), and have been implicated 
in the immunopathogenesis of autoimmunity (17).
The major mechanisms determining maturation stages during 
B-ontogeny from recently emerging B cells to terminally differ-
entiated IgA+ plasma cells have not been fully clarified. However, 
cytokines, such as IL-10 and CD4+ T-regulatory cells (Tregs), are 
known to be important in this process. Accordingly, reduced Treg 
numbers have been reported in IgAD (18). IL-10 has furthermore 
repeatedly been shown to induce IgA production in IgAD B cells 
(19) with and without other cytokines such as IL-4 and IL-21 
(20) in germinal center mimicking stimulations. However, these 
stimulations have not been shown to induce long-lived antibody 
responses. The induction of B-cell differentiation through the 
activation of innate immune pathways has been shown to be a 
strong inducer of IgA, presumably due to the key role of IgA in the 
innate and adaptive interactions in the gut where this isotype is 
most prevalent (21). No functional analysis exists of TLR9-driven 
B-cell activation in IgAD.
In this study, we evaluate the phenotype of PB T and B lym-
phocytes from IgAD individuals and the role of TLR9 in B cell 
maturation and IgA induction in IgAD.
resUlTs
Demographics of study group
To analyze IgA deficiency, we harvested blood from deficient 
donors from the Icelandic IgAD cohort (3). The demographics 
and laboratory values of IgAD individuals and HC are shown in 
Table  1. No demographic differences were found between the 
two study groups. However, the IgAD group had significantly 
higher levels of total IgG with significantly higher IgG1 and 
higher autoantibody positivity as has previously been described 
(Table 1).
igaD individuals have Decreased 
Frequencies of Transitional B cells
Through the use of multicolor flow cytometric analyses our 
understanding of the various lymphocyte sub-phenotypes and 
their different biology and function has been greatly enhanced. 
Thus, in order to elucidate this pattern for adult IgAD the 
FigUre 1 | B cells in IgA-deficient individuals lack IgA, but have increased IgG surface expression. The figure shows B cell populations as measured by  
flow cytometry comparing selective IgA deficiency (IgAD) donors to healthy controls (HC). (a) Percentage of naïve (CD20+CD27−), memory (CD20+CD27+), and 
plasmablasts (CD20−CD27+) as % of CD19+ B cells are shown. No significant differences are seen for these populations between IgAD and HC. (B) Representative 
pie chart for frequencies of Ig isotypes expressed on total CD19+ B cells in IgAD and HC donors. The fraction is reduced for IgA (p < 0.0009) positive B cells and 
increased for IgG (p < 0.029) positive B cells in IgAD compared to HC. (c) The percentages of class-switched (CD20+CD27+IgD+) memory CD19+ B cells in IgAD 
individuals and HC. IgAD donors have significantly less class-switched memory B cells. (D) The proportion of CD19+ B cells expressing chemokines associated  
with gut homing; CD62L, α4β7, CCR10, and CXCR4, is comparable in IgAD individuals and HC. (e) The activation of plasmablasts/plasma cells in IgAD evaluated 
by percentage of HLA-DR expression shows comparable activation in IgAD and HC. All data are from five-independent experiments, no duplicates. Significance  
was calculated in relation to control group determined by one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001.
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following subsets were evaluated in the PB compartment of 
our IgAD study group and compared to HC. These include 
transitional (CD24hi/CD20+/CD38hi/CD27−), mature-naïve 
(CD20/CD27−), memory (CD20+/CD27+), and antibody secret-
ing cells (CD20−/CD27hi). In addition, and to further delineate 
the phenotypic characteristics of these B  cell subpopulations 
in IgAD, the expression of CD21, CD62L, CCR10, β7, CXCR4, 
kappa light chain, lambda light chain, IgM, IgG, IgD, and IgA was 
assessed as well. As expected the fraction of naïve, memory, and 
antibody secreting populations were found to be normal in IgAD 
(Figure 1A). The analysis of IgA, IgG, IgM, and IgD expression 
on total B cells demonstrates a defect in IgA expressing B cells 
(fivefold reduction compared to HC), together with significantly 
increased expression of IgG+ B  cells within the IgAD group 
(Figure 1B). As could be expected and previously been shown by 
others (12) class-switched memory B cells (CD20+CD27+IgD−) 
were significantly decreased in our IgAD study group and non-
class-switched B cells (CD20+CD27+IgD+) were similarly found 
to be increased (Figure  1C). The expression of the mucosal 
CXCR4, CCR10, and α4β7 homing receptors were also assessed 
in memory B cells with no difference observed between IgAD 
and HC (Figure 1D). The fraction of plasmablasts was normal 
in IgAD individuals indicating that even though a major part of 
B cells with a plasmablast phenotype (CD19+CD20−CD27hi) have 
been shown to be IgA+ in normal individuals, the increase in 
the IgG+ fraction compensates for this loss in IgAD (22). Finally, 
plasmablasts were found to be within normal range in the IgAD 
individuals, and not with an activation HLADR+ phenotype 
(Figure 1E).
Transitional B cells Producing il-10 are 
Decreased in igaD individuals
To examine non-antibody dependent B cell responses in IgAD, 
transitional B  cells were analyzed and found to be of lower 
proportion in the IgAD group compared to the HC, p < 0.02, 
Figure 2A. This was observed both in their frequency (Figure 2A) 
and total numbers (transitional B  cell total numbers: IgAD; 
5,649 ± 3,126 vs. HC; 2,183 ± 5,837; p < 0.02). In addition, their 
number did not correlate with the age of the IgAD individu-
als studied. Due to the observed transitional B  cell deficiency 
in IgAD it was important to assess their functionality further. 
FigUre 2 | CD24hiCD38hi transitional B cells in selective IgA deficiency (IgAD) individuals are defective in their numbers, inducibility, and IL-10-secreting properties. 
The figure shows transitional B cells as measured ex vivo in PBMCs and after in vitro stimulation of B cells by CpG for 48 h and regulatory B cells (Bregs) as 
measured by flow cytometry comparing IgAD and controls. (a) B cells with a transitional B cell phenotype (CD24hiCD38hi) are of lower fraction in IgAD individuals 
compared to healthy controls (HC) before stimulation and (B) after stimulation. Both IgAD and HC do though respond to CpG, as the fractions of the transitional 
population are increased after stimulation. (c) Evaluation of Breg function by the measurement of intracellular IL-10 demonstrate a lower fraction of IL-10+ Bregs 
(CD24hiCD38hiIL-10+) in IgAD compared to HC. A measurement of intracellular TNF-α in transitional B cells shows no difference between the two groups. In all 
figures, HC are depicted as white, while IgAD individuals are depicted as black bars. Data are shown as mean ± SEM of all IgAD and HC assessed. All data are  
from five-independent experiments, no duplicates. Significance was calculated in relation to the control group. *p < 0.05, **p < 0.01, ***p < 0.001 (one sided 
Student’s t-test).
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An emerging role for transitional B  cells is their ability to be 
induced to produce IL-10 through TLR9 stimulation. Therefore, 
CD19+ B cells isolated from IgAD individuals were stimulated 
with CpG for 48 h prior to the addition of Brefeldin A, PMA, 
and ionomycin. As shown in Figure 2B, even under such strong 
inducing transitional B-cell differentiation conditions, this 
phenotype remained significantly reduced in the IgAD group. 
In addition, the fraction of IL-10+ expressing CD20+CD24hiCD38hi 
transitional B cells in vitro was decreased in IgAD individuals 
(CD20+CD24hiCD38hiIL-10+), Figure  2C. This was not due to 
an overall decrease in cytokine production, since the fraction 
of TNFα+ transitional B cells was normal (CD20+CD24hiCD38
hiTNFα+).
stimulation by cpg Fails to normalize  
iga Production in igaD individuals
Since CpG-driven stimulation revealed a defective transi-
tional B-cell differentiation and IL-10 expression investigated 
whether B cells from IgAD could be induced by CpG to pro-
duce IgA with the addition of exogenous IL-10. As could be 
expected CpG-induced B-cell stimulation led to a significant 
IgA secretion and surface expression in HC, however, this was 
not observed in IgAD individuals (Figures  3A,C). In addi-
tion, even under maximal stimulatory conditions including 
CpG with exogenous IL-10 administration this defect was not 
reverted (Figures  3A,C). Finally, this was further reflected 
by a higher production of IgG seen in IgAD individuals after 
CpG stimulation alone when compared to healthy controls. 
IgG surface expression and secretion remained higher in IgAD 
compared to HC after CpG-driven stimulation (Figures 3B,D). 
The same was seen for CPG+IL-10 stimulation for all, but IgG 
production where differences were not as big and failed to reach 
significance.
igaD individuals have a normal Proportion 
and Function of classical T-cell 
subpopulations
Antibody production can be heavily influenced by T cell signal-
ing with subpopulations of T cells influencing different isotype 
switching as well as being important in germinal center B cell 
maturation. Therefore, a detailed phenotypic analysis of the 
various subpopulations of T-cells was performed. Our results 
suggest that proportions of CD3+, CD4+, and CD8+T cells are 
comparable in IgAD individuals compared to healthy donors 
(Figure  4A). Additionally, no differences were seen between 
the two groups for any of the measured CD4+ (Figure 4B) and 
CD8+(Figure  4C) T-cell subpopulations. The expression of 
surface markers CD27, CD28, CD62L, and CCR7 was used to 
define the following T cell subpopulations (flow cytometry gat-
ing depicted in Figure S1C in Supplementary Material); naïve 
(CD62L+CCR7+), central memory (CD62L−CCR7+), effector 
memory (CD62L−CCR7−), terminally differentiated effector 
memory (CD62L+CCR7−), early differentiated (CD27+CD28+), 
intermediately differentiated (CD27+CD28−), or late differenti-
ated (CD27−CD28−) T cells. T-effector functions were further 
assessed by the stimulation of PBMCs with PMA and iono-
mycin in the presence of brefeldin A followed by staining for 
detection of intracellular cytokines and transcription factors. 
Such stimulation did not reveal any significant difference of 
the various effector T-cell subpopulations between IgAD and 
HC in the following T-effector cell types (Figure 4D): T folli-
cular helper cell (TFH) (CD4+CXCR5+ICOS+ programmed cell 
death protein 1 (PD1+) B-cell lymphoma 6 protein (BCL6+), 
TH1 (CD4+ T-box transcription factor TBX21+CXCR3+IL-
17−IFNγ+), TH2 [CD4+CCR4+trans-acting T-cell-specific 
transcription factor(GATA3+)IL-10−IL-4+], TH17 (CD4+CC
R4+RORγT+IL-17+), and TH22 (CD4+IL-22+).
FigUre 3 | The lack of IgA surface expression and production is not corrected by TLR9 stimulation in selective IgA deficiency (IgAD) individuals. The figure shows 
the responsiveness of isolated CD19+ B cells in IgAD individuals and healthy controls (HC) after 7 days of CpG or CpG with IL-10 stimulation as evaluated by IgA 
and IgG expression and secretion evaluated by flow cytometry and enzyme-linked immunosorbent assay. IgAD donor B cells express a lower proportion of IgA  
(a) and high of IgG (B) following CpG stimulation. This unresponsiveness is not overcome by the addition of IL-10 (a,B). In HC, an increase is seen in the proportion 
of IgA but not IgG positive B cells when IL-10 is added to the CpG stimulation (a,B). IgA production (c) is seen following CpG stimulation in HC but not in IgAD 
individuals. Defective IgA secretion is not rescued in CpG stimulated IgAD B cells by the addition of IL-10. On the contrary, IgG production is significantly higher in 
IgAD individuals compared to HC after CpG stimulation (D). This difference is less distinct after the addition of IL-10 and is not statistically significant. In all figures, 
HC are depicted as white, while IgAD individuals are depicted as black bars. Data are shown as mean ± SEM of all IgAD and HC assessed. All data are from 
five-independent experiments, no duplicates. Significance is shown as *p < 0.05, **p < 0.01, ***p < 0.001 (as determined by one-way ANOVA).
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natural and induced Tregs have normal 
numbers and Function in igaD
Previous studies have shown an interaction between IL-10+ Bregs 
and Tregs. Since Bregs were shown to be abrogated in IgAD, 
a phenotypic analysis of Tregs was undertaken. To fully under-
stand the role of Tregs in the pathophysiology of diseases and 
defects one needs to look both at the natural Tregs (nTregs), 
induced Tregs (iTregs), and their function. nTregs were measured 
in PBMCs stimulated in vitro for 4 h with PMA and ionomycin 
and in the presence of brefeldin A (Figure  5A). iTregs were 
induced from isolated CD4+CD25− T cells by stimulating them 
with anti-CD28, IL-2, and transforming growth factor beta 1 
(TGF-β1) on anti-CD3ε-coated plates. No differences were 
seen between IgAD individuals and HCs for either population 
(Figures 5A,B). We further assessed the functional capacity of 
these iTregs in a previously published model using proliferation 
of fluorescent 5,6-carboxyfluorescein succinimidyl ester (CFSE) 
stained CD8+ T  cells (from HC) in a co-culture with iTregs 
(from IgAD or HC) and super antigen-pulsed Epstein–Barr 
transformed B cells (EBV-B) cells. The iTregs from IgAD indi-
viduals showed normal suppressive capacity compared to iTregs 
from HC at the different dilutions of iTregs: EBV from 1:1 to 1:32 
(Figures 5C,D).
il-10 Fails to act as a Mediator of  
B-cell longevity in igaD individuals
IL-10 has previously been shown to induce a short-lived 
increase in IgA production in IgAD (19). Our findings showed 
that Bregs secreting IL-10 are defective after TLR9 stimulation 
in IgAD, prompted us to explore this further especially, since 
exogenous cytokine stimulation has been proposed as treatment 
in PIDs such as IgAD and CVID (20). In a model mimicking 
a long-lived in  vivo mucosal IgA [previously described in Ref. 
(23)], we explored whether B cells cultured together with other 
PBMCs and exogenous IL-10 could be forced into class switch-
ing and sustaining long-lived ex vivo IgA production. Robust IgA 
FigUre 4 | The main T cell subsets are of normal proportions in selective IgA deficiency (IgAD). The figure shows T cell populations as measured by flow cytometry 
on PBMCs for extracellular markers and on PBMCs stimulated with PMA and ionomycin for 4 h comparing IgAD and controls. No significant differences were found 
for the proportions of T cells. (a) The fraction of CD3+ T cell as proportions of lymphocytes and CD4+ and CD8+T cells as proportions of CD3+ T cells in IgAD vs. 
healthy controls (HC). (B) Fractions of the different T cell subpopulations of CD4+ and (c) CD8+ T cells. The subpopulation gating is based on their classification as 
naïve (CD62L+CCR7+), central memory (CD62L−CCR7+), effector memory (CD62L−CCR7−), terminally differentiated effector memory (CD62L+CCR7−), early 
differentiated (CD27+CD28+), intermediately differentiated (CD27+CD28−), or lately differentiated (CD27−CD28−). (D) The figures show the proportions of T helper cell 
populations as a fraction of CD4 T cells. No significant differences were seen between T follicular helper cell [CD4+CXCR5+ICOS+ programmed cell death protein 1 
(PD1+) B-cell lymphoma 6 protein+], TH1 (CD4+T-box transcription factor TBX21+CXCR3+IL-17−IFNγ+), TH2 [CD4+CCR4+trans-acting T-cell-specific transcription 
factor (GATA3+) IL-10−IL-4+], TH17 (CD4+CCR4+RORγT+IL-17+), and TH22 (CD4+IL-22+) cells between IgAD and healthy controls. All data are from five-independent 
experiments, no duplicates. Significance was calculated in relation to the control group. *p < 0.05, **p < 0.01, ***p < 0.001 (as determined by one-way ANOVA).
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levels were detected in healthy donors for 3–5 weeks following 
stimulation, but only weak IgA levels were detected in IgAD 
donor cultures, and no longer detected after 2  weeks, indicat-
ing only short-lived responses following stimulation in IgAD 
(Figure  6A). The opposite was found for IgG production in 
IgAD, where a long-lived response was seen for up to 3 weeks 
and with a significantly higher production on week 2 follow-
ing IL-10 stimulation (Figure  6B). The difference between the 
two groups of donors reached significance for the first 3 weeks 
for conditions with and without IL-10. This model demonstra-
ted that IL-10 stimulation in the presence of other immune cells 
induces only a modest, short-lived IgA production in IgAD 
individuals, but leads instead to robust IgG responses, in stark 
contrast to the response observed in all HC.
DiscUssiOn
In this study, we identify a defect in the cellular phenotype of 
IgAD B cells and their responses to TLR9 stimulation. The defect 
in PB is present as previously shown as a reduction in class-
switched B cells (CD20+CD27+IgD+) but also in their precursors; 
CD19+CD24hiCD38hi transitional B cells. After CpG stimulation 
of PBMCs IgA production remained defective in IgA-deficient 
individuals and they had significantly fewer IL-10+ transitional 
Breg cells compared to HC.
It has been demonstrated that antibody memory may not 
only be due to antigenic recall, but also due to nonspecific 
recall through interactions between components of the innate 
immune system and B cells. The effect of TLR9 stimulation has 
been repeatedly shown to induce antigenic responses both from 
memory and naïve B cells, pointing toward a mechanism where 
both antigenic recall and nonspecific recall may coexist (24). The 
stimulation through TLR9 in B cells has furthermore been shown 
to preferentially induce the IgA isotype, and more efficiently than 
other more conventional stimulations with CD40 ligand, anti-Ig, 
and cytokines (14). In IgA deficiency, certain germinal center 
mimicking antigen-dependent stimulations have been shown to 
induce IgA production while nothing is known about the effects 
of TLR stimulations on IgA production in IgAD.
TLR9 stimulation has been shown to prolong the lifespan of 
mature-naïve B cells in vitro (24). This has been hypothesized 
to maintain the normal B  cell compartment. However, this 
proposed mechanism is challenged for IgA-producing B  cells 
by normal numbers of CD19+ B  cells found in our study. In 
contrast with our findings in adults, children with IgAD have 
been recently found to have normal numbers of transitional 
B cells numbers. In that same publication, the transitional B cell 
compartment is shown to be very different compared to adults 
(14). This could coincide with the fact that immune dysregula-
tion develops at an increasing age in IgAD. We do not think the 
FigUre 5 | The numbers, inducibility, and functions of Tregs are not hampered in selective IgA deficiency (IgAD). The figure shows natural Tregs (nTregs) as 
measured by flow cytometry on ex vivo PBMCs (a), induced Tregs (iTregs) on CD4+CD25− T cells stimulated for 4 days by anti-CD3ε, anti-CD28, IL-2, and 
transforming growth factor beta 1 (B), and suppressive capacity of the iTregs as measured by a suppression assay with super antigen-pulsated Epstein–Barr 
transformed B cells (EBV-B) cells and allogenic PBMCs (c), comparing IgAD and controls. (a) The proportion of cells expressing a CD4 nTreg phenotype 
characterized by CD4+CD127 −CD25hiforkhead boxP3(FoxP3hi) expression was not found to differ in IgAD from healthy controls (HC). (B) Neither did in vitro induced 
CD4+ iTregs after 4 days of stimulation. (c) The suppressive capacity of the iTregs from IgAD is intact and comparable to HC at different ratios when comparing 
proliferation of fluorescent 5,6-carboxyfluorescein succinimidyl ester (CFSE) stained CD8 T cells in allogeneic co-cultured PBMCs stimulated by super antigen-
pulsated EBV-B cells. (D) A representative experiment showing a HC and an IgAD individual in a suppressive assay, −CFSE is a negative control with no staining, 
−Tregs shows a positive control of proliferation without Tregs. All data are from five-independent experiments, no duplicates. Significance was calculated in relation 
to the control group. *p < 0.05, **p < 0.01, ***p < 0,001 (as determined by one-way ANOVA).
FigUre 6 | The IgA production induced by IL-10 does not result in a long-lived response in selective IgA deficiency (IgAD) individuals. The figure shows the antibody 
response of B cells from IgAD and healthy controls (HC) PBMCs with or without IL-10 stimulation as measured by enzyme-linked immunosorbent assay. (a) IgG 
production is statistically higher in IgAD individuals compared to HC at week 1 with production seen up to 5 weeks. (B) A small amount of IgA production is seen at 
week 1 in PBMCs from IgAD individuals with the exogenous addition of IL-10 (with—▾/or without IL-10 Δ), it remains significantly lower at 1 week compared to HC 
(with—○/or without IL-10 ◽), with production seen up to the fifth week in HC but not IgAD. Significance was calculated in relation to the control group. *p < 0.05, 
**p < 0.01, ***p < 0.001 (as determined by one-way ANOVA).
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observed TLR9 defect in IgAD cells reflects a geronto immuno-
logical mechanism (23) since our IgAD group contained had 
only 2 individuals out of 15 above the age of 65 and only 1 in 
the HC, with no correlation observed between transitional cell 
number and age (Figure S2B in Supplementary Material).
Regulatory B cells (Bregs, CD24hiCD38hiIL-10+) have been of 
great interest in recent years and are known to be inducible by 
TLR9 ligand CpG (17). In this study, we evaluated IL-10 expres-
sion in TLR9-stimulated B cells. IgAD individuals were found to 
have significantly lower numbers of IL-10+CD24hiCD38hi Bregs 
after in vitro CpG stimulation.
Our results are on the whole mostly in agreement with what 
has been described in the literature, with the exception that 
we do not observe T  cell defects in the main CD4 and CD8 
populations, nor in Tregs. In contrast, Tregs have been shown to 
be of decreased proportions in a subgroup of IgAD individuals 
with chronic inflammation (18). Our observations are of inter-
est, since Bregs are known to induce differentiation of Tregs, 
which are themselves a powerful inducer of IgA production. 
The previous reported differences in Tregs of IgAD donors did 
not contain our strict Tregs definition strategy (25). Our gat-
ing using CD4+CD25hiCD127−forkhead box P3(FoxP3hi) Tregs 
in IgAD showed both normal numbers of nTregs and iTregs 
with normal suppressive function in an induced inflammation 
model. This is important, since the sole use of nTregs in groups 
prone to inflammation, and immune dysregulation could be 
misleading and has been shown to be greatly enhanced by 
functional assessment (26). Due to the difficulties involved in 
recruiting rare donors from a small population such as Iceland, 
the IgAD cohort consisted of only 15 participants. The limited 
number of subjects included in the study could possibly have 
caused us to miss some subtle differences in cellular variations 
possibly detectable in a bigger cohort, which could have been 
sub-grouped with regards to clinical symptoms displayed by the 
participants.
The absence of IgA production observed following CpG 
stimulation demonstrates a defective T  cell-independent res-
ponse of B cells in IgA deficiency as opposed to prior findings 
indicating a defective T  cell-dependent inducibility of IgA. 
However, the IL-10 defect seen following CpG is in concord-
ance with these previous findings (19, 20). These previous 
studies showing short-lived IgA responses in IgAD following 
IL-10, taken together with the IL-10 defect we observed in 
Bregs, made us reason that naïve or memory B cells from IgAD 
donors stimulated with IL-10 or IL-10 inducing stimulations in 
their most physiological environment might mature to become 
long-lived IgA producing plasma cells. To evaluate this, PBMCs 
were stimulated and repeatedly evaluated for their IgA and 
IgG production. As expected, IL-10 did induce a very strong- 
and long-lived response in HC. However, it failed to do so in 
IgAD individuals, inducing only a weak surge in the first week 
(Figure 5A).
Prior results have repeatedly described the rescue of IgA 
production in IgAD with germinal center mimicking stimula-
tions (19, 20, 27), while our model, which in contrast mimicks 
the TLR9-driven gut innate—adaptive immune interactions, was 
unable to correct the IgA defect. Our findings demonstrate a 
novel TLR9-mediated defect in IgAD at the interface of the innate 
and adaptive immune system.
TLR9 stimulation is one of the strongest IgA inducers and the 
IgAD defect is much more pronounced in gut-mimicking condi-
tions than that which is seen for T cell-dependent stimulations 
(Figures S2C,D in Supplementary Material). Interestingly, IgG 
was seen at higher concentration in IgAD individuals compared 
to HC after this in vitro stimulation, reflecting the respective con-
centrations in serum. Although others have witnessed the same 
phenomenon, to our knowledge no reports have demonstrated 
a mechanism for this concomitant IgG increase, which is not 
observed in other hypogammaglobinemias. We do not believe 
this to be an effect of bypassing faulty IgA production at the 
level of gene class-switch recombination, since constant regions 
gamma 1 and gamma 3, encoding for isotypes IgG1 and IgG3 
which are both increased in IgAD (28), precede the first alpha 
chain (encoding for IgA1). This fact points toward a mechanism 
related to biological preference via signaling instead of practi-
cal bypassing during genetic recombination in the B  cell. It is 
intriguing that although potent T  cell-dependent stimulations 
have shown to be able to nearly normalize IgA production in 
IgAD (19, 20) in our hands, the T cell subpopulations which are 
important in inducing class switch recombination are normal, 
both with regards to serum proportions and cytokine and 
transcription factor expression. We, therefore, hypothesize the 
defect to be on the B cell side, at the early differentiation stage 
of B cells close to their emergence from the bone marrow and in 
their TLR9 stimulation pathway.
Finally, our observations with respect to TLR responses 
may be relevant to normal and pathological immune responses 
beyond IgA deficiency. For example, transitional B cell defects 
and TLR defects have been seen in other PIDs, autoimmune 
infectious, and atopic diseases and can be affected by novel 
biologics used for the treatment of autoimmunity. These obser-
vations in combinations with a better insight into the underlying 
defect responsible for IgAD could lead to a deeper understand-
ing of the responsiveness of innate signaling in B cells and its 
importance for immune homeostasis. However, a more com-
prehensive analysis of the transcriptomic changes occurring in 
B cells after TLR stimulation would be required to elucidate the 
biological processes and pathways involved.
MaTerials anD MeThODs
study Population
Peripheral blood from 15 IgA-deficient individuals (median age 
51, range 39–76  years) with known IgAD from the Icelandic 
IgAD group were collected into heparinized tubes after obtain-
ing informed consent (in accordance with procedures approved 
by The National Bioethics Committee and The Data Protection 
Authority in Iceland). These were compared to gender and age 
matched HC (median age 57, range 39–79 years).
isolation of PBMcs, B, and T cells
Peripheral blood mononuclear cells (PBMCs) were isolated 
from heparinized peripheral blood using Ficoll–Paque gradient 
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centrifugation (Sigma-Aldrich, St. Louis, MO, USA). CD19+ 
B cells were isolated by magnetic bead-based positive selection 
using Dynabeads and DETACHaBEAD CD19 (Invitrogen). 
CD4+ T  cells were isolated with Dynabeads CD4 (invitrogen) 
and CD25+ T cells were depleted from the CD4+ T cell popula-
tion using Dynabeads CD25 (invitrogen). All isolations were 
done according to the manufacturer’s instructions. The purity of 
isolated CD19+ B cells was consistently >95% as analyzed by flow 
cytometry.
Flow cytometric analysis
For extracellular staining single-cell suspensions were prepared and 
surface molecules were stained for 20 min at 4°C with a stain for 
viable cells using LIVE/DEAD fixable Yellow stain kit (Invitrogen) 
and optimal dilutions of antibodies for the follow ing anti-human 
mAb: CD3 PE-Cy7 (UCHT1), CD3 PerCP-Cy5.5 (OKT3), CD4 
eFluor 450 (RPA-T4), CD8a APC-eFluor 780 (RPA-T8), CD19 
PerCP-Cy5.5 (HIB19), CD20 APC-eFluor 780 (2H7), CD24 
PE-Cy7 (eBioSN3), CD25 PE (BC96), CD27 eFluor 450 (eBioSN3), 
CD38 PE-eFluor 610 (HIT2), CD45RO PE (UCHL1), CD45RA 
(JS-83), CD127 FITC (eBioRDR5), CD194 (CCR4), PerCP-
eFluor 710 (D8SEE), CD278 (ICOS) APC (ISA-3), CD279 PD-1 
(EH12.2H7), IgM FITC (SA-DA4), HLA-DR eFluor 450 (L243), 
CCR10 PE (6588-5), CCR7 (3D12), β7 (FIB504), CCR4 (D8SEE), 
and CD185 (CXCR5) APC (MU5UBEE) all from affy metrix eBio-
science; CD3 Brilliant Violet 510 (OKT3), CD14 Brilliant Violet 
510 (M5E2), CD62L FITC (DREG-56), IgD Alexa Fluor 700 
(IA6-2), CXCR4 (12G5) all from Biolegend, IgG PE (JDC-10) 
from abcam, and IgA APC (IS11 8E10) from Miltenyi-Biotec.
For intracellular staining single-cell suspensions were prepared 
and surface molecules were stained as described above. They were 
subsequently fixed with paraformaldehyde and permeabilized 
with either 0.5% saponine or FoxP3/transcription factor stain-
ing set (catalog nr 00-5523-00, eBio-sciences, San Diego, CA, 
USA), stained according to the manufacturer’s instructions for 
the following anti-human mAb: FoxP3 APC (236A/E7), T-bet 
PerCP-Cy5.5 (eBio4B10), BCL-6 PerCP-eFluor 710 (BCL-UP), 
GATA3 eFluor 660 (TWAJ), TNF alpha PE (MAb11), IL-4 PE 
(8D4-8), IL-6 Alexa Fluor 700 (MQ2-13A5), IL-10 Alexa Fluor 
488 (JES3-9D7), IL-17 PE (eBio64CAP17), and IL-22 PE-Cy7 
(22URTI) all from affymetrix eBioscience, IFNγ APC (4S.B3) 
from Biolegend. To assess proliferation fluorescent 5,6-carboxy-
fluorescein succinimidyl ester (Life Technologies) labeling was 
used according to manufacturer’s instructions. Stained cells were 
subsequently analyzed using 10 colors Beckman Coulter Navios 
Flow Cytometer.
B cell culture conditions
Isolated CD19+ B cells were cultured in Iscove’s modified Dulbecco’s 
medium (IMDM) supplemented with 10% heat-inactivated fetal 
calf serum (FCS), penicillin/streptomycin (100 U/ml), and 2 mM 
Glutamax in 96-well round bottom plates at a density of 50 × 104 
cells/well. T cell-independent mimicking stimulations were per-
formed in 96-well round bottom plates in the presence of CpG-
ODN2006 (1 µg/ml TLR9 agonist, InvivoGen). T cell-dependent 
mimicking stimulations were performed in 96-well round bot-
tom plates with 0.5  µg/ml mouse anti-human-CD40 antibody 
(Ebioscience #16-0409-85), 5 µg/ml goat anti-human-IgM anti-
body (Jackson Immuno Research Laboratories, West Grove, PA, 
USA) with or without the presence of IL-10 (Invitrogen, 50 ng/ml). 
Assessment of the induced transitional CD24hiCD38hi phenotype 
and Bregs was done on B cells harvested after 48 H CpG (1 µg/ml) 
stimulation. They were further blocked with brefeldin A for 
6 h and re-stimulated with PMA and ionomycin for 4 h for the 
assessment of cytokine producing B  cells by intracellular flow 
cyto metry. For the assessment of TLR9 responsiveness of B cells 
they were cultured further and assessed for surface expression 
of antibody isotypes and production of immunoglobulins 
after 7  days. Supernatants were harvested and cells stained for 
flow cytometric analysis.
a Model for the assessment of the 
spontaneous Production of iga by B cells
To assess spontaneous IgA production in IgAD after stimulation 
with IL-10, PBMCs were cultured at a density of 2 × 105 cells/well 
in IMDM supplemented with 10% heat-inactivated FCS, peni-
cillin/streptomycin (100 U/ml), and 2 mM Glutamax with and 
without the exogenous addition of IL-10 as previously described 
(29). Supernatants were collected at day 7, 14, 21, and 34 and 
replaced each time with the same amount of medium without 
additional stimuli. The collected supernatants were further 
measured by enzyme-linked immunosorbent assay (ELISA) to 
assess IgA and IgG production.
T cell culture conditions
T helper cell subsets were assessed by intracellular flow cyto-
metry on PBMCs stimulated in 96-well round bottom plates 
with PMA and ionomycin for 4 h. T regulatory cell induction 
was done by culturing CD4+CD25− isolated T  cells in serum-
free medium (Aim V, Invitrogen) in 96-well round bottomed 
cell culture plates with plate bound anti-CD3ε (UCHT) with 
soluble anti-CD28 for 120 h with IL-2 (100 IU/ml) and TGF-β1 
(10 ng/ml) (antibodies and cytokines used are from R&D Systems, 
Abingdon, UK) for 5 days and then harvested to measure their 
maturation as induced Tregs (iTregs) by FACS. Their suppressive 
capacity was assessed as previously described (30) after harvest 
by co-culturing Tregs with CFSE labeled allogeneic PBMC’s 
and super antigen-pulsated Epstein–Barr transformed B  cells 
(EBV-B  cells) in Aim V serum-free medium (Invitrogen). 
Staphylococcal enterotoxins (SEA, SEB, and SEE, Toxin Tech-
nologies, 1  µg/ml of each) were used for 2  h pulses before 
wash ing three times with PBS. The PBMCs: EBV-B  cells and 
iTregs: EBV-B cells ratio was constant at 10:1 while the iTregs: 
PBMCs ratio varied from 1:1 to 1:32. The cells were harvested 
after 3 days and the suppressive capacities of iTregs assessed by 
flow cytometric analysis by proliferation calculations.
Measurement of igg and iga by elisa
IgG, IgA, and IgM measurements were done with a standard kit 
from Bethyl Laboratories for the quantification of production 
in culture supernatants according to the manufacturer’s instruc-
tions as previously described (Bethyl Laboratories, E88-102 and 
E88-104) on 96 well plates (Nunc maxisorp plates, Denmark).
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Measurement of autoantibodies
For the determination of cyclic citrulinated peptides in human 
sera, the Immunoscan CCplus® test kit (Euro Diagnostica AB, Lun-
davägen 151, SE-212 24 Malmö, Sweden) was used. The screening 
for rheumatoid factor (RF) was performed using ELISA techni que 
(Anti-Human Kappa Light Chain, Sigma). Antinuclear anti bodies 
were assessed by indirect immunofluorescence (IIF) using rat 
tissue (ANA) is a screening for non-organ-specific antibodies.
Flow cytometric analysis
Proliferation calculations were done using Flow Jo Tree star 
V7.6.5. Expression of cell surface markers was measured by flow 
cytometry and analyzed using Flow Jo Tree star VX.0.7. Basis of 
gates was determined with the use of fluorescence minus one 
(FMO) together with appropriate isotype controls. Results are 
presented as average with SEM.
statistical analysis
Statistical analyses and graphs were made using GraphPad Prism 
(V 5.04 GraphPadSoftware Inc., for windows, La Jolla, CA, USA). 
Normality of the data was assessed using Kolmogorov–Smirnov 
test. Majority of obtained values were different from normal, 
therefore, the nonparametric Mann–Whitney U-test was per-
formed. Results are expressed as mean ± SEM. Probability values 
<0.05 were considered significant.
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FigUre s1 | Gating hierarchy to identify subsets of T and B lymphocytes. 
The figure shows the gating strategy described in the methods for T and 
B cells. (a) Cells were first identified based on forward scatter and side 
scatter and doublets excluded by forward area and forward height 
properties. (B) B cells were identified based on their expression of CD19, 
while excluding CD14+ and CD3+ positive cells and dead cells. Then a 
gating was done based on CD19 and CD27 to get CD19loCD27hi B cells. 
B cells were further analyzed based on their different expression of CD20 
and CD27 for naïve, memory, and plasmablasts/plasma cells; CD24 and 
CD38 for transitional B cells, IgD, and CD27 for class-switched memory 
B cells. A gating is shown for HLADR expression on plasmablasts/plasma 
cells and for the expression of IgA and IgG in both healthy controls (HC)  
and IgAD individuals on plasmablasts/plasma cells. (c) T cells were 
identified based on their expression of CD3 and furthermore evaluated  
for their expression of CD4 and CD8. The subsets were subsequently 
analyzed for their expression of CD28 vs. CD27 and CCD62L vs. CCR7. 
Natural Tregs and induced Tregs cells were assessed based on their 
expression of CD4, CD127 negativity, CD25hi, and CD127hi expression.  
As can be seen, the expression is greatly enhanced by stimulation for 
5 days with IL-2 and TGF-β.
FigUre s2 | Stimulation responses of B cells, age distribution of transitional 
cell fractions, and B cell responses in selective IgA deficiency (IgAD) and healthy 
controls (HC) to T cell-dependent and T cell-independent stimuli. (a) IgA 
production as measured by enzyme-linked immunosorbent assay (ELISA) from 
HC isolated B cells after different stimuli. CD40 ligand (CD40L), anti IgM, IL-10, 
IL-2, IL-4, and CpG. Each bar represents five independent individuals tested in 
two different experiments. (B) Age distribution of transitional B cells in IgAD and 
HC. The line shows a linear regression for transitional B cell fractions compared 
to age, no correlation is seen, R2 = 0.01923, p = 0.5. (c) IgA production as 
measured by ELISA and (D) Expression following stimulation in HC but not in 
IgAD individuals CD40L, anti IgM with or without IL-10, and CpG with and 
without IL-10 in IgAD and HC.
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